Singapore markets closed
Straits Times Index
3,215.07 -0.33 (-0.01%) S&P 500
4,337.44 +17.38 (+0.40%) Dow
34,006.88 +43.04 (+0.13%) Nasdaq
13,271.32 +59.51 (+0.45%) Bitcoin USD
26,269.18 +257.71 (+0.99%) CMC Crypto 200
562.37 +2.86 (+0.51%)
InMode Ltd. (INMD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 32.28 |
| Open | 32.16 |
| Bid | 32.00 x 800 |
| Ask | 32.53 x 800 |
| Day's range | 31.93 - 32.45 |
| 52-week range | 27.25 - 48.25 |
| Volume | |
| Avg. volume | 1,284,749 |
| Market cap | 2.698B |
| Beta (5Y monthly) | 2.12 |
| PE ratio (TTM) | 15.58 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- CNW Group
InMode Receives Health Canada Certification of Forma-I for Dry Eye Disease Due to Meibomian Gland Dysfunction
InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, is proud to announce the Health Canada license of the Forma-I to address the symptoms of dry eye disease due to Meibomian gland dysfunction (MGD). Forma-I is intended for use in the periorbital area and eyelids and relieves inflammation of meibomian glands and eye irritation.
© 2023 Yahoo. All rights reserved.
